American Herbal Products Association (AHPA) > News > AHPA Updates

AHPA Updates

Updates on AHPA activities and resources delivered to your inbox. Subscribe today!

IADSA update on international supplement regulations

IADSA update on international supplement regulations

September 2020 IADSA Newsflash

In this issue of the IADSA Newsflash:  France alerts consumers about food supplements with claims of curing or preventing COVID-19; Israel notifies WTO about revised limits for polyaromatic hydrocarbons (PAHs) in food supplements; Brazil's new resolution mandating a label when food supplements have a new formulation; Ecuador issues rules for cannabis (hemp seed) supplements; and Peru has established a basic regulation governing health claims applicable to supplement products.

Supplement and Hemp Industry Associations Applaud Bipartisan Legislation to Regulate Hemp-Derived CBD

September 4, 2020: Bill directs FDA to use its authority and resources to set a clear regulatory framework for hemp and hemp derived CBD

the four leading dietary supplement industry associations applaud Representative Kurt Schrader (D-OR) and Representative Morgan Griffith (R-VA), for introducing bipartisan legislation that would protect public health by providing legal clarity in the cannabidiol (CBD) product marketplace. The Hemp and Hemp derived CBD Consumer Protection and Market Stabilization Act of 2020 directs the U.S. Food and Drug Administration (FDA) to use its authority and resources to set a clear regulatory framework for hemp and hemp derived CBD and assure consumer protection.
AHPA Hemp-CBD Supplement Virtual Congress

AHPA Hemp-CBD Supplement Virtual Congress

On-demand -- Recorded Aug. 27, 2020

AHPA's second, annual Hemp-CBD Supplement Congress was presented on August 27, 2020 and provides companies with an understanding of federal and state legal and regulatory obligations and current issues and opportunities in the hemp-CBD market. This event delivers the latest information to you on-demand.

September 2020 AHPA Report

AHPA Members, Log in to access the AHPA Report

The September 2020 AHPA Report includes: Inaugural Sports Nutrition Congress; Hemp-CBD Supplement Congress now on-demand; 9th Annual Botanical Congress; AHPA seeks more time for small firms to comply with new labeling rules; Statement on oleandrin; Senator hoping for sensible guidance on CBD; Hemp-CBD market growth; and more.

AHPA Virtual Sports Nutrition Congress

On demand -- Recorded Oct. 21

AHPA presented the inaugural Virtual Sports Nutrition Congress to on Oct. 21 to showcase industry and sports nutrition experts who covered key sport nutrition industry issues by providing the most up-to-date information, resources and practical tools and guidelines to help ensure the long-term success of your business. This event is now available on-demand.

AHPA updates online Botanical Safety Handbook

AHPA updates online Botanical Safety Handbook

New safety information added to 11 botanicals

AHPA continues to expand and update the online Botanical Safety Handbook 2nd ed. to provide the herbal industry with comprehensive safety information on over 500 species of herbs from clinical trials, pharmacological and toxicological studies, medical case reports, and historical texts. New safety information has been added to entries on 11 botanicals.

AHPA joins request to give small firms more time to meet new FDA food labeling rules

AHPA urges FDA to extend enforcement discretion to small firms

AHPA joined 16 other trade associations in a Aug. 21 letter to the Food and Drug Administration (FDA) to request more time for small businesses to understand and comply with the Agency’s new, wide-ranging nutrition labeling regulations.

AHPA Statement on oleandrin and Nerium oleander

AHPA strongly discourages sales or marketing of dietary supplements that contain any part of the oleander plant

Over the last few days, the potential use of oleandrin for treatment of COVID-19 has received significant media attention. The American Herbal Products Association (AHPA) strongly discourages sales or marketing of dietary supplements that contain any part of the oleander plant (Nerium oleander) or its constituent, oleandrin. AHPA also urges physical and online retailers to refrain from offering any such products for sale, and AHPA cautions consumers to avoid oral consumption of oleander or oleandrin.

AHPA supports USDA proposed rule to allow pullulan in products labeled organic

AHPA also supports comments submitted by the Organic Trade Association (OTA)

AHPA expresses support for adding pullulan to the National List as a nonagricultural (nonorganic) ingredient for use only in tablets and capsules for dietary supplements labeled, “Made with organic (specified ingredients or food group(s))."

August 2020 AHPA Report

AHPA Members, Log in to access the AHPA Report

The August 2020 AHPA Report includes: FDA announces resumption of domestic inspections; Daily consumption of certain cranberry products reduces risk of recurrent UTIs; Final guidance on BE labeling; Virtual Hemp-CBD Supplement Congress on Aug. 27; and more.

RSS
12345678910 Last